Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma

BACKGROUND: Aurora kinases are key regulators of cell cycle and represent new promising therapeutic targets in several human tumours. METHODS: Biological relevance of Aurora kinase-A and -B was assessed on osteosarcoma clinical samples and by silencing these genes with specific siRNA in three human...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavanti, E, Sero, V, Vella, S, Fanelli, M, Michelacci, F, Landuzzi, L, Magagnoli, G, Versteeg, R, Picci, P, Hattinger, C M, Serra, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833226/
https://www.ncbi.nlm.nih.gov/pubmed/24129234
http://dx.doi.org/10.1038/bjc.2013.643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833226/
https://www.ncbi.nlm.nih.gov/pubmed/24129234
http://dx.doi.org/10.1038/bjc.2013.643

Ejemplares similares